Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
Net sales $ 91,942 $ 5,508 $ 176,242 $ 369,690
Cost of sales 1,511,360 930,164 3,259,335 2,327,770
Gross loss (1,419,418) (924,656) (3,083,093) (1,958,080)
Operating expenses        
Selling, general and administrative 3,949,081 1,996,054 9,514,868 4,086,944
Research and development 1,616,604 1,216,727 3,518,840 2,579,002
Total operating expenses 5,565,685 3,212,781 13,033,708 6,665,946
Other income 0 0 864,900 0
Loss from operations (6,985,103) (4,137,437) (15,251,901) (8,624,026)
Interest expense, net 124,346,806 15,922,763 111,323,317 17,700,346
Loss before provision for income taxes (131,331,909) (20,060,200) (126,575,218) (26,324,372)
Provision for income taxes 0 0 0 0
Net loss $ (131,331,909) $ (20,060,200) $ (126,575,218) $ (26,324,372)
Net loss attributable to common stockholders per share - basic and diluted (in dollars per share) $ (1.76) $ (0.33) $ (1.77) $ (0.44)
Weighted average number of common shares outstanding - basic and diluted (in shares) 74,701,343   71,583,551 60,530,168